drug
Lyumjev
Marketedupdated 3mo agoby Eli Lilly and Co
Approvedcommunity read0 votes
indications
investigational
Type 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying Lyumjev
- phase1A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- N/AUltrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes
- phase4A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
- phase1A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that